Deerfield Management LXRX Position
Exited3-Fund ConvergenceDeerfield Management exited their position in LEXICON PHARMACEUTICALS, INC. (LXRX) in Q1 2024, after holding the stock for 2 quarters.
The position was first reported in Q4 2023 and has been tracked across 2 quarterly 13F filings.
LXRX is a convergence signal: 3 specialist biotech funds hold this stock, suggesting high institutional conviction.
Deerfield Management LXRX Position History
Frequently Asked Questions
Does Deerfield Management own LXRX?
No. Deerfield Management exited their position in LEXICON PHARMACEUTICALS, INC. (LXRX) in Q1 2024. They previously held the stock for 2 quarters.
How many hedge funds own LXRX?
3 specialist biotech hedge funds currently hold LXRX, including BVF Partners, OrbiMed Advisors, Tang Capital Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deerfield Management first buy LXRX?
Deerfield Management's position in LXRX was first reported in Q4 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deerfield Management's LXRX position increasing or decreasing?
Deerfield Management completely exited their LXRX position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
LXRXCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deerfield ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →